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1. INTRODUCTION 
For full calcium-sensitive control of the ac- 
tomyosin ATPase of both vertebrate skeletal and 
cardiac muscle, the concerted action of both 
troponin (Tn) and tropomyosin (TM) are required 
[1,2]. In contrast, the inhibition of the actomyosin 
ATPase, but not the calcium-triggered release of 
inhibition, can be mediated by TnI and TM alone 
[3-51. Though TnI, the inhibitory subunit of the 
troponin complex, possesses the ability to inhibit 
the ATPase activity of actomyosin itself, this in- 
hibition, at ionic strengths where TM by itself 
neither binds nor inhibits, is greatly enhanced by 
the addition of TM [3,5-81. At ionic strengths 
where binding and inhibition by TM is significant, 
TnI enhances the inhibition [3,5]. 
The mechanism of regulation proposes that, in 
the absence of Ca’+, corresponding to the relaxed 
state, the position of TM and TnI are such as to 
prevent the actin-myosin interaction. In the 
presence of Ca’+, corresponding to contraction, 
Ca2+ binds to TnC causing conformational 
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Rabbit skeletal muscle 
changes that are transmitted to TnI, TnT and TM, 
resulting in movement of both TnI and TM on the 
actin filament such that the actomyosin ATPase is 
activated (reviews [9- 111). 
Though the inhibitory effects of TnI [3-81 and 
the TnI-TnT complex, which produces a 
Ca2+-independent inhibition of the actomyosin 
ATPase similar to TnI alone, are well documented 
[4,12,13], no demonstration of an inhibitory role 
for TnT (pure preparations of TnT devoid of TnI 
contamination) has been made. This communica- 
tion is the first report of a substantial inhibition of 
the actomyosin ATPase by rabbit skeletal TnT in 
the presence of TM. This inhibition is compared to 
that of TnI and native troponin. 
2. MATERIALS AND METHODS 
2. I. Protein preparations 
Rabbit skeletal troponin and troponin subunits 
were prepared as in [14]. a-Tropomyosin was 
prepared from rabbit hearts and purified as in [ 151. 
Actin was purified from rabbit skeletal muscle 
acetone powder as in [ 161. Myosin Sl was made as 
in [17] except for the elution conditions on the 
DEAE-cellulose column [18]. The two peaks of Sl 
eluting from the column corresponding to myosin 
Sl containing the Al or A2 light chains were pool- 
ed together and the mixture used in all ex- 
periments. Protein concentrations were determin- 
ed either by amino acid analysis or absorbance 
372 
Published by Elsevier Biomedical Press 
00145793/83/0000-0000/$3.00 0 Federation of European Biochemical Societies 
Volume 153, number 2 FEBS LETTERS March 1983 
measurements at 280 nm with the extinction coef- 
ficients summarized in [ 181. SDS-urea-poly- 
acrylamide gel electrophoresis was done as in [ 191 
except that the gel was 15% polyacrylamide, 0.1% 
SDS and 6 M urea in 0.375 M Tris-HCI (pH 8.8). 
2.2. ATPase assays 
ATPase assays (2 ml) were performed on a pH 
stat apparatus as in [20]. The actin-activated 
ATPase was measured, unless otherwise stated, in 
30 mM KCI, 0.1 mM EGTA, 5 mM MgC12,2 mM 
disodium ATP and 2 mM Tris at pH 7.8. Assays 
to investigate the effect of a-tropomyosin on the 
actin-activated ATPase of Sl (fig.1) were carried 
out as follows: The ATP hydrolysis rate in the 
absence of regulatory proteins was taken as 100. 
TM was added to the assay, and its effect on the 
hydrolysis rate recorded (a separate assay was car- 
ried out for each of the TM concentrations 
shown). After addition of TM, Tn was added to 
the assay vial. The Tn concentration was kept con- 
stant at -1: 7 with respect to actin. Finally, 
0.2 mM calcium was added to the assay (giving 
0.1 mM ‘free’ calcium) to provide an estimate of 
calcium-sensitive release of inhibition. 
In fig.2,3, the acto-Sl-TM ATPase activity was 
taken as 100. Inhibitor was added to the assay and 
its effect on the hydrolysis rate recorded (a 
separate assay was carried out for each inhibitor 
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Fig. 1. Effect of cY-tropomyosin on the acto-Sl-ATPase. 
The assay contained 4pM Sl, 2 PM actin and 0.25 pM 
troponin. a-TM was varied from O-1.15 PM: (H) 
effect of TM alone on the ATPase activity in the absence 
of calcium; (M and O---G) the ATPase activity of 
TM-Tn in the absence and presence of Ca’+, 
respectively. The ATPase activity of act081 was taken 
as 100. The arrow indicates a molar ratio of TM/actin 
of l/7. 
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Fig.2. Inhibition of the acto-Sl-TM-ATPase by native 
Tn, TnI and TnT. The acto-Sl-TM-ATPase activity 
was taken as 100. All assays contained a molar ratio of 
Sl :actin:TM of 14:7: 1. The open and closed symbols 
represent wo different preparations of actin and Sl: (0) 
TnI; (o,o) native Tn; (A) TnT. Inset: SDS-urea 
Laemmli gel electrophoresis of TnT and native Tn. 
concentration shown). The only exception to this 
procedure was in fig.3C, where increasing concen- 
trations of TnC were added to one assay vial in the 
presence of calcium and one assay vial in the 
absence of calcium. Similar results were obtained 
by the above method. The ATPase activities of 
acto-Sl -TM varied from 322-35 1 nmol 
POd.min-‘.mg Sl-’ depending on the prepara- 
tion used. In all experiments, the concentrations of 
Sl were either 3 PM or 4 PM. Sl : actin was always 
2: 1. 
TnT and TnI are well known for their solubility 
problems. In these experiments, both were dissolv- 
ed (-3 mg/ml) in 8 M urea 1 M KCl-2 mM 
DTT-10 mM Tris-HCI buffer (pH 7.8) dialyzed 
firstly against 1 M KCl-2 mM DTT-10 mM 
Tris-HCl buffer (pH 7.8) and finally against 
a.5 M KCI-2 mM DTT-10 mM Tris-HCl buffer 
(pH 7.8). Control experiments indicated that the 
small increase in KC1 concentration from the titra- 
tion of TnI or TnT in 0.5 M KC1 did not affect the 
ATPase assay. 
3. RESULTS AND DISCUSSION 
Here, we have chosen Sl :actin ratios in the 
ATPase assay to examine the inhibition of TnI, Tn 
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Fig.3. Inhibition and release of inhibition of acto-Sl-TM-ATPase. The acto-Sl-TM-ATPase activity was taken as 100. 
All assays contained amolar ratio of Sl : actin :TM of 14 :7 : 1. (A) (--+ ) Molar ratio of Tn:TM of 1: 1; (C--O and 
M) ATPase activity of Tn in the absence and presence of Ca”, respectively. (B) (0-a) Inhibition by TnI; 
(H and &---J) release of inhibition of TnC in the absence and presence of Ca’+, respectively. (C) (*) Inhibition 
by TnT alone; (M and +---+) effect of TnC on the inhibition of TnT in the absence and presence of Ca*‘, 
respectively. 
and TnT such that TM does not inhibit but slightly 
potentiates the actin-activated ATPase (fig. 1). 
Potentiation by tropomyosin of the acto- 
Sl-ATPase has been observed in [13,21-251. 
Under the conditions used in this assay (30 mM 
KCI, 5 mM MgCla and 2 mM ATP) tropomyosin 
has been shown to bind to F-actin [3]. However, 
with Sl : actin at 2 : 1, tropomyosin alone no longer 
inhibits the acto-Sl-ATPase, but potentiates 
124,251. Addition of troponin resulted in an inhibi- 
tion of the ATPase and the calcium-sensitive 
release of inhibition approached 220% higher than 
the original acto-S 1 activity. 
The effectiveness of TnI, Tn and TnT to inhibit 
the acto-Sl-TM-ATPase was examined in fig.2. 
TnI and native Tn were equally effective in in- 
hibiting the ATPase (A) whereas TnT was -t-fold 
less effective than TnI or native Tn (B). All 3 in- 
hibitors were capable of reducing the ATPase ac- 
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tivity to 30%. This is the first report of a signifi- 
cant inhibition of the acto-S 1 -TM-ATPase (70%) 
by TnT. Previous workers have shown a small in- 
hibition by TnT using different ATPase assay con- 
ditions. However, it was concluded that the inhibi- 
tion was probably due to small contamination of 
TnT by TnI [12,13]. In this study, we have 
prepared TnT devoid of any contamination by 
other troponin components as shown by the SDS 
gel electrophoresis patterns in fig.2. 
Fig.3 compares the release of inhibition of 
native Tn by calcium and the release of inhibition 
of TnI and TnT by calcium and TnC. Almost com- 
plete inhibition of the acto-Sl-TM-ATPase was 
achieved at a 1: 1 molar ratio of Tn to TM (A). 
Calcium results in release of the inhibition and 
potentiation of the ATPase. When the acto- 
Sl-TM-ATPase is inhibited by TnI, addition of 
TnC results in a partial release of inhibition in the 
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absence of calcium (fig.3B). Complete release of 
inhibition is only obtained with TnC in the 
presence of calcium (fig.3B). The partial (25%) 
Ca2+ sensitivity which is observed is the result of a 
difference in binding of the IC complex to 
TM-actin in the presence and absence of calcium. 
That is, the IC complex binds to TM-actin only in 
the absence of calcium and not in the presence of 
calcium where TnC can dissociate TnI from the 
TM-actin filament [26-281. TnI and TnC form a 
1: 1 complex in the absence or presence of Ca2+ 
[29-311. Maximum release of TnI inhibition by 
TnC in the presence or absence of Ca2+ occurs at 
a 1: 1 molar ratio (fig.3B). The difference in in- 
hibiting power between TnI and IC complex 
(minus Ca2+) can be explained by the structural 
change induced in TnI by TnC [32,33]. 
When the acto-Sl-TM-ATPase is inhibited by 
TnT, addition of TnC does not release the inhibi- 
tion in the absence of Ca2+ but does show a partial 
release in the presence of Ca2+ (fig.3C). The partial 
(35%) Ca2+ sensitivity can be explained by both 
structural change induced in TnT by TnC and the 
stronger interaction in the presence of Ca2+ 
[34-371. The maximum release of inhibition of 
TnT by TnC in the presence of Ca2+ occurs at a 
TnC/TnT molar ratio of 3: 1 (fig.3C) which 
reflects a much weaker binding between TC com- 
plex compared to the IC complex. The IC complex 
in the presence of Ca2+ is stable in 6 M urea 
[29,31]. 
The inhibitory role of TnT demonstrated here is 
a reasonable observation, since TnT binds to all 
components (TnI, TnC and TM) of the regulatory 
complex and the Ca2+ -induced conformational 
changes in TnC are transmitted through TnT to 
TM-actin. TnT interacts extensively with TM 
(essentially the COOH-terminal half of TM, in- 
cluding the head-to-tail overlap region) [38,,39]. 
TM can either inhibit or activate the acto- 
Sl-ATPase and has been shown to occupy at least 
3 positions on actin [25]. Since TnT binds to TM, 
and weakly if at all to actin, it must be altering the 
position of TM on actin from the non-inhibitory to 
the inhibitory state under the conditions reported 
here. The ability of TnT to affect the inhibitory 
role of TnI in the absence of TM has also been 
demonstrated [4], where the IT complex was able 
to inhibit in a similar fashion to TnI-TM. Ob- 
viously, the concerted effects of TM, TnI, TnT 
and TnC are required to obtain complete regula- 
tion (inhibition, release of inhibition, 
potentiation). 
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